BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32138790)

  • 1. Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS).
    Farkas B; Boldizsar F; Bohonyi N; Farkas N; Marczi S; Kovacs GL; Bodis J; Koppan M
    J Ovarian Res; 2020 Mar; 13(1):25. PubMed ID: 32138790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated interleukin-10 and sex steroid levels in peritoneal fluid of patients with ovarian hyperstimulation syndrome.
    Manolopoulos K; Lang U; Gips H; Braems GA
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 99(2):226-31. PubMed ID: 11788177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B; Aboulghar M; Smitz J; Ron-El R
    Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.
    Aboulghar MA; Mansour RT; Serour GI; El Helw BA; Shaarawy M
    Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):81-5. PubMed ID: 10579621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome.
    Friedlander MA; Loret de Mola JR; Goldfarb JM
    Fertil Steril; 1993 Nov; 60(5):826-33. PubMed ID: 8224268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome.
    Abramov Y; Schenker JG; Lewin A; Friedler S; Nisman B; Barak V
    Hum Reprod; 1996 Jul; 11(7):1381-6. PubMed ID: 8671471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome.
    Chen CD; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS
    Fertil Steril; 1999 Aug; 72(2):286-92. PubMed ID: 10438997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated concentrations of angiogenin in serum and ascitic fluid from patients with severe ovarian hyperstimulation syndrome.
    Aboulghar MA; Mansour RT; Serour GI; Elhelw BA; Shaarawy M
    Hum Reprod; 1998 Aug; 13(8):2068-71. PubMed ID: 9756270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.
    Pellicer A; Albert C; Mercader A; Bonilla-Musoles F; Remohí J; Simón C
    Fertil Steril; 1999 Mar; 71(3):482-9. PubMed ID: 10065786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome.
    Revel A; Barak V; Lavy Y; Anteby E; Abramov Y; Schenker JJ; Amit A; Finci-Yeheskel Z; Mayer M; Simon A; Laufer N; Hurwitz A
    Fertil Steril; 1996 Jul; 66(1):66-71. PubMed ID: 8752613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management.
    Delbaere A; Bergmann PJ; Gervy-Decoster C; Staroukine M; Englert Y
    Fertil Steril; 1994 Oct; 62(4):731-7. PubMed ID: 7926081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome.
    Kobayashi H; Okada Y; Asahina T; Gotoh J; Terao T
    J Mol Endocrinol; 1998 Jun; 20(3):363-74. PubMed ID: 9687159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD11c+HLA-DR+dendritic cells and related cytokines in the follicular fluid might be related to pathogenesis of ovarian hyperstimulation syndrome.
    Shi SL; Peng ZF; Yao GD; Jin HX; Song WY; Yang HY; Xue RY; Sun YP
    Int J Clin Exp Pathol; 2015; 8(11):15133-7. PubMed ID: 26823856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
    Abramov Y; Barak V; Nisman B; Schenker JG
    Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
    Abramov Y; Schenker JG; Lewin A; Kafka I; Jaffe H; Barak V
    Fertil Steril; 2001 Jul; 76(1):51-7. PubMed ID: 11438319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of intercellular adhesion molecule-1 and E-selectin in the pathogenesis of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Gemer O; Cherneva S
    Akush Ginekol (Sofiia); 2005; 44(4):26-31. PubMed ID: 16028375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome.
    Itskovitz-Eldor J; Kol S; Lewit N; Sealey JE
    J Clin Endocrinol Metab; 1997 Feb; 82(2):461-4. PubMed ID: 9024237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of montelukast and cabergoline for prevention of ovarian hyperstimulation syndrome: in an experimental rat model.
    Akman L; Sahin G; Erbas O; Aktug H; Akdogan A; Goker EN; Taskiran D; Tavmergen E
    Gynecol Endocrinol; 2015 May; 31(5):369-73. PubMed ID: 25599748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma immunoglobulins in patients with severe ovarian hyperstimulation syndrome.
    Abramov Y; Naparstek Y; Elchalal U; Lewin A; Schechter E; Schenker JG
    Fertil Steril; 1999 Jan; 71(1):102-5. PubMed ID: 9935124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of soluble urokinase plasminogen activator receptor (suPAR) in the pre-ovulatory follicular fluid is associated with development of ovarian hyperstimulation syndrome during ovarian stimulation.
    Grynnerup AG; Toftager M; Zedeler A; Bogstad JW; Prætorius L; Grøndahl ML; Yding Andersen C; Sørensen S; Pinborg A; Løssl K
    J Assist Reprod Genet; 2018 Dec; 35(12):2187-2193. PubMed ID: 30232642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.